Ra Medical Systems' delayed 10-Q filing indicates that the company needs more time to finalize its financial statements and complete the review process. This may cause short-term uncertainty for investors, as they may be concerned about the company's financial health and transparency. This uncertainty could potentially lead to a negative impact on the stock price in the short term.